Four external appointments include new digital innovation
leader, head of global strategy and two Operating Unit President
roles within the Neuroscience Portfolio
DUBLIN, Nov. 15, 2021 /CNW/ -- Medtronic plc
(NYSE:MDT) today announced four executive appointments to further
its commitment to become the global leader in healthcare
technology.
- Bob Hopkins, head of
global strategy, effective today.
- Mei Jiang, new global
digital innovation leader, effective today.
- Harry "Skip" Kiil, President of the Cranial and Spinal
Technologies (CST) Operating Unit, effective Jan. 4, 2022.
- Mira Sahney, President of
the Pelvic Health Operating Unit, effective Dec. 6, 2021.
"We're making bold moves to lead in healthcare technology and be
a destination for world-class talent," said Geoff Martha, Medtronic Chairman and Chief
Executive Officer. "These executive appointments bring outside-in
thinking, new skills and capabilities, and diverse perspectives to
our already talented leadership team – and will continue to power
Medtronic's transformation."
Bob Hopkins, head of global
strategy
Hopkins will join as head of global strategy.
Hopkins comes from Bank of America Merrill Lynch, where he has
served as Managing Director since 2008, covering the medical
technology industry, including Medtronic. Hopkins has worked with
the medtech industry for more than 25 years. He has been the #1
ranked analyst in the sector for the past three years in
Institutional Investor's annual survey, and ranked in the top three
for the past 17 years.
In his role, Hopkins will partner with Medtronic senior
leadership in the areas of strategy, business development, capital
deployment and investor communication. His broad, global
perspective, including insights into the companies, technologies,
and trends impacting healthcare and the medical technology industry
will help Medtronic continue to navigate the rapidly evolving
industry.
Mei Jiang, head of global
digital innovation
Jiang will join Medtronic from Iron
Mountain, where she served as Senior Vice President, Global Head of
Innovation, Product & Solutions.
Prior to Iron Mountain, Jiang spent six years at HP, where she
most recently served as Head of Digital Innovation & Business
Transformation, and Cisco, where she was Founder/CEO of a
management consulting startup. Since 2000, she has led three
startups into accelerated growth, and has served on multiple boards
for Silicon Valley startups.
Jiang is also a member of the Forbes Technology Council and
founding member of "Chief"; a private network designed for women
leaders — rising VP level through CEO — to strengthen their
experience in the C-suite.
In her new role, Jiang will work with leaders across the
organization to test, expand, and accelerate Medtronic's data,
digitization, and AI strategies, globally. This work includes using
data and AI to enhance internal processes, as well as establishing
new business models leveraging existing capabilities and
technologies. She'll transform the company's core markets and
businesses using the insights of data and AI, as well as establish
enterprise-wide capabilities and resources needed to support this
transformation.
Harry "Skip" Kiil, President, Cranial and Spinal Technologies
Operating Unit
Kiil will join Medtronic from Smith+Nephew,
where he was President of the Global Orthopaedics business,
responsible for the company's reconstructive arthroplasty,
robotics, trauma, and extremities businesses. Kiil has extensive
experience in spine and orthopaedics, deep understanding of
international markets, and expertise in leveraging technology to
create and deliver an integrated ecosystem at scale.
Previously, Kiil was Executive Vice President and President of
Global Commercial Operations at NuVasive, Inc. He also served as
Surgical Head, Europe,
Middle East, Africa, and Russia, in the Alcon Eye Care Division of
Novartis Corporation, where he was responsible for leading the
commercial transformation of the surgical business across developed
and emerging growth markets. Before joining Alcon, Kiil spent 12
years with Stryker Corporation, where he held several leadership
roles, including Vice President and General Manager for
Europe, and General Manager for
Japan.
In his new role, Kiil will be responsible for driving innovation
and delivering therapies to markets around the world more quickly
and effectively and cultivating a strong culture within Cranial and
Spinal Technologies.
Mira Sahney, President, Pelvic
Health Operating Unit
Sahney brings more than 25 years of
executive leadership experience in the development and
commercialization of innovative medical technologies across
gynecology, ENT, orthopaedics, and medical robotics. Sahney will
leverage her deep background in mergers and acquisitions, product
marketing, and commercial strategy to lead the Pelvic Health
operating unit into the increasingly competitive future of the
incontinence market.
Sahney joins Medtronic from Hyalex Orthopaedics — a start-up
medical device company based in Lexington, Massachusetts — where she has
served as Chief Executive Officer and a member of the Board of
Directors since 2017. In this role, she formed its investment
syndicate and built a world-class organization.
Prior to Hyalex, Sahney held a number of business leadership
roles with Smith+Nephew, including Senior Vice President and
General Manager of ENT and Gynecology. She also led the sale of
Smith+Nephew's gynecology business to Medtronic in 2016.
Before her tenure with Smith+Nephew, Sahney was President, CEO
and Co-Founder of Myomo, Inc., an award-winning medical robotics
start-up that went public in 2017. Her early career included a
variety of supply chain, engineering, strategy, product management,
product development, research and software roles at Flow
International, the BMW Group and Boeing.
In her new role, Sahney will be responsible for driving
innovation and expanding access to more patients around the world,
while cultivating a strong culture within Pelvic Health.
About Medtronic
Bold thinking. Bolder actions. We are
Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global
healthcare technology company that boldly attacks the most
challenging health problems facing humanity by searching out and
finding solutions. Our Mission — to alleviate pain, restore health,
and extend life — unites a global team of 90,000+ passionate people
across 150 countries. Our technologies and therapies treat 70
health conditions and include cardiac devices, surgical robotics,
insulin pumps, surgical tools, patient monitoring systems, and
more. Powered by our diverse knowledge, insatiable curiosity, and
desire to help all those who need it, we deliver innovative
technologies that transform the lives of two people every second,
every hour, every day. Expect more from us as we empower
insight-driven care, experiences that put people first, and better
outcomes for our world. In everything we do, we are engineering the
extraordinary. For more information on Medtronic (NYSE:MDT), visit
www.Medtronic.com and follow @Medtronic on Twitter and
LinkedIn.
Any forward-looking statements are subject to risks and
uncertainties such as those described in Medtronic's periodic
reports on file with the Securities and Exchange Commission. Actual
results may differ materially from anticipated results.
Contacts:
|
|
|
|
Erika
Winkels
|
Ryan
Weispfenning
|
Public
Relations
|
Investor
Relations
|
+1-763-526-8478
|
+1-763-505-4626
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medtronic-taps-top-digital-and-healthcare-technology-leaders-to-drive-company-transformation-301423692.html
SOURCE Medtronic plc